{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:00:50Z","timestamp":1790802050869,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,28]]},"DOI":"10.1097\/qad.0b013e32831db232","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T03:51:53Z","timestamp":1233546713000},"page":"343-353","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy and tolerability of initial antiretroviral therapy: a systematic review"],"prefix":"10.1097","volume":"23","author":[{"given":"Andrew","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: recommendations of the International AIDS Society \u2013 USA Panel","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1293.2006.00424.x","article-title":"British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy","volume":"7","author":"Gazzard","year":"2006","journal-title":"HIV Med"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(06)69638-4","article-title":"Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses","volume":"368","author":"Chou","year":"2006","journal-title":"Lancet"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/01.aids.0000247578.08449.ff","article-title":"An updated, systematic overview of triple combination therapy in antiretroviral-na\u00efve, HIV-infected adults","volume":"20","author":"Bartlett","year":"2006","journal-title":"AIDS"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/QAD.0b013e328133f285","article-title":"Antiretroviral Therapy (ART) Cohort Collaboration. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies","volume":"21","author":"May","year":"2007","journal-title":"AIDS"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/135965350300800411","article-title":"Once-a-day therapy for HIV infection: a controlled, randomised study in antiretroviral-na\u00efve HIV-1-infected patients","volume":"8","author":"Maggiolo","year":"2003","journal-title":"Antiviral Ther"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/135965350200600404","article-title":"Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz","volume":"6","author":"Maggiolo","year":"2002","journal-title":"Antiviral Ther"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"R15-8-20210130","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/QAD.0b013e328270b877","article-title":"Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score","volume":"21","author":"Mocroft","year":"2007","journal-title":"AIDS"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/QAD.0b013e3282f08cdc","article-title":"Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy.","volume":"21","year":"2007","journal-title":"AIDS"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"R19-8-20210130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4 count-guided interruption of antiretroviral treatment.","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","article-title":"CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection","volume":"22","author":"Baker","year":"2008","journal-title":"AIDS"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200901280-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:33:19Z","timestamp":1786037599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200901280-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32831db232","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}